Clewell Rebecca A, Andersen Melvin E
The Hamner Institutes for Health Sciences, Research Triangle Park, NC 27709-2137 , USA
The Hamner Institutes for Health Sciences, Research Triangle Park, NC 27709-2137 , USA.
Mutagenesis. 2016 May;31(3):333-40. doi: 10.1093/mutage/gev078. Epub 2016 Feb 4.
Assessing the shape of dose-response curves for DNA-damage in cellular systems and for the consequences of DNA damage in intact animals remains a controversial topic. This overview looks at aspects of the pharmacokinetics (PK) and pharmacodynamics (PD) of cellular DNA-damage/repair and their role in defining the shape of dose-response curves using an in vivo example with formaldehyde and in vitro examples for micronuclei (MN) formation with several test compounds. Formaldehyde is both strongly mutagenic and an endogenous metabolite in cells. With increasing inhaled concentrations, there were transitions in gene changes, from activation of selective stress pathway genes at low concentrations, to activation of pathways for cell-cycle control, p53-DNA damage, and stem cell niche pathways at higher exposures. These gene expression changes were more consistent with dose-dependent transitions in the PD responses to formaldehyde in epithelial cells in the intact rat rather than the low-dose linear extrapolation methods currently used for carcinogens. However, more complete PD explanations of non-linear dose response for creation of fixed damage in cells require detailed examination of cellular responses in vitro using measures of DNA damage and repair that are not easily accessible in the intact animal. In the second section of the article, we illustrate an approach from our laboratory that develops fit-for-purpose, in vitro assays and evaluates the PD of DNA damage and repair through studies using prototypical DNA-damaging agents. Examination of a broad range of responses in these cells showed that transcriptional upregulation of cell cycle control and DNA repair pathways only occurred at doses higher than those causing overt damage fixed damage-measured as MN formation. Lower levels of damage appear to be handled by post-translational repair process using pre-existing proteins. In depth evaluation of the PD properties of one such post-translational process (formation of DNA repair centers; DRCs) has indicated that the formation of DRCs and their ability to complete repair before replication are consistent with threshold behaviours for mutagenesis and, by extension, with chemical carcinogenesis.
评估细胞系统中DNA损伤的剂量-反应曲线形状以及完整动物中DNA损伤后果,仍然是一个有争议的话题。本综述通过甲醛的体内实例以及几种测试化合物诱导微核(MN)形成的体外实例,探讨细胞DNA损伤/修复的药代动力学(PK)和药效学(PD)方面,以及它们在定义剂量-反应曲线形状中的作用。甲醛既是强诱变剂,也是细胞内的内源性代谢物。随着吸入浓度增加,基因变化出现转变,从低浓度时选择性应激途径基因的激活,到较高暴露水平时细胞周期控制、p53-DNA损伤和干细胞生态位途径的激活。这些基因表达变化更符合完整大鼠上皮细胞中对甲醛的PD反应的剂量依赖性转变,而不是目前用于致癌物的低剂量线性外推方法。然而,要更完整地从PD角度解释细胞中产生固定损伤的非线性剂量反应,需要使用在完整动物中不易获得的DNA损伤和修复测量方法,对体外细胞反应进行详细研究。在本文的第二部分,我们展示了我们实验室的一种方法,即开发适用的体外试验,并通过使用典型DNA损伤剂的研究来评估DNA损伤和修复的PD。对这些细胞中广泛反应的研究表明,细胞周期控制和DNA修复途径的转录上调仅在高于导致明显损伤(以MN形成衡量的固定损伤)的剂量时发生。较低水平的损伤似乎通过使用预先存在的蛋白质的翻译后修复过程来处理。对一种这样的翻译后过程(DNA修复中心;DRCs的形成)的PD特性的深入评估表明,DRCs的形成及其在复制前完成修复的能力与诱变的阈值行为一致,进而与化学致癌作用一致。